• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌药物相关性假膜性结肠炎患者粪便中的艰难梭菌和细胞毒素。

Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.

作者信息

George W L, Rolfe R D, Harding G K, Klein R, Putnam C W, Finegold S M

出版信息

Infection. 1982;10(4):205-8. doi: 10.1007/BF01666910.

DOI:10.1007/BF01666910
PMID:7129642
Abstract

Thirty patients with antimicrobial agent-associated pseudomembranous colitis (PMC) were studied for the presence of Clostridium difficile and its cytotoxin in feces. Either colonoscopy or barium enema radiography was required in three patients for the diagnosis of PMC because of nondiagnostic findings at sigmoidoscopy. Both the organism and cytotoxin were detected in 27 of the 30 patients; Staphylococcus aureus was excluded as the cause of PMC in two of the remaining patients. Eighteen of 19 patients with C. difficile-induced PMC who were treated with oral vancomycin had a salutary response; seven patients, however, had a relapse of colitis following the discontinuation of vancomycin. In general, relapses of colitis responded to retreatment with vancomycin. The implication of C. difficile as a cause of diarrhea is best achieved by the demonstration of colonic mucosal plaques or of a pseudomembrane. The value of fecal culture for C. difficile and cytotoxin assay is limited by the existence of asymptomatic carriers.

摘要

对30例抗菌药物相关性假膜性结肠炎(PMC)患者的粪便进行艰难梭菌及其细胞毒素检测。3例患者因乙状结肠镜检查无诊断性发现,需行结肠镜检查或钡剂灌肠造影以诊断PMC。30例患者中27例检测到该菌及细胞毒素;其余2例患者排除金黄色葡萄球菌为PMC病因。19例接受口服万古霉素治疗的艰难梭菌所致PMC患者中,18例有良好反应;然而,7例患者在停用万古霉素后结肠炎复发。一般来说,结肠炎复发对再次使用万古霉素治疗有反应。通过显示结肠黏膜斑块或假膜,最能说明艰难梭菌是腹泻的病因。无症状携带者的存在限制了艰难梭菌粪便培养和细胞毒素检测的价值。

相似文献

1
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.抗菌药物相关性假膜性结肠炎患者粪便中的艰难梭菌和细胞毒素。
Infection. 1982;10(4):205-8. doi: 10.1007/BF01666910.
2
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.艰难梭菌及其细胞毒素在抗菌药物相关性腹泻及其他病症患者粪便中的情况。
J Clin Microbiol. 1982 Jun;15(6):1049-53. doi: 10.1128/jcm.15.6.1049-1053.1982.
3
Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects.抗菌药物相关性结肠炎和腹泻:历史背景与临床方面
Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S208-13. doi: 10.1093/clinids/6.supplement_1.s208.
4
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.抗生素相关性结肠炎的复发:万古霉素治疗期间艰难梭菌的内源性持续存在。
Gut. 1983 Mar;24(3):206-12. doi: 10.1136/gut.24.3.206.
5
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.来自不同患者群体的艰难梭菌分离株的分离率和产毒潜力。
Gastroenterology. 1981 Jul;81(1):5-9.
6
Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.住院患者腹泻粪便中的艰难梭菌及其细胞毒素。分离株的产毒潜力。
Ann Biol Clin (Paris). 1989;47(2):67-70.
7
Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin.伪膜性结肠炎:两种细胞毒性梭状芽孢杆菌的分离及万古霉素治疗成功案例
Can Med Assoc J. 1978 Nov 4;119(9):1058-60.
8
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.复发性假膜性结肠炎,与既往抗生素治疗无关。
Arch Intern Med. 1981 Apr;141(5):663-4.
9
Cytotoxin and enterotoxin production by Clostridium difficile.艰难梭菌产生的细胞毒素和肠毒素
Microbiologica. 1984 Oct;7(4):375-9.
10
Clostridium difficile colitis.艰难梭菌结肠炎
Adv Intern Med. 1984;29:85-107.

引用本文的文献

1
Host response to Clostridium difficile infection: Diagnostics and detection.宿主对艰难梭菌感染的反应:诊断与检测。
J Glob Antimicrob Resist. 2016 Dec;7:93-101. doi: 10.1016/j.jgar.2016.08.002. Epub 2016 Sep 20.
2
Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.艰难梭菌毒素的快速检测及艰难梭菌感染的实验室诊断
Infection. 2017 Jun;45(3):255-262. doi: 10.1007/s15010-016-0940-9. Epub 2016 Sep 6.
3
SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model.

本文引用的文献

1
Clinical and laboratory observations in Clostridium difficile colitis.艰难梭菌结肠炎的临床及实验室观察
Am J Clin Nutr. 1980 Nov;33(11 Suppl):2521-6. doi: 10.1093/ajcn/33.11.2521.
2
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.抗菌药物所致结肠炎和腹泻的治疗与预防。
Gastroenterology. 1980 Aug;79(2):366-72.
3
Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study.结肠镜检查在抗生素相关性结肠炎诊断中的应用。一项前瞻性研究。
SMT19969 作为艰难梭菌感染的治疗药物:使用传统药敏试验和体外肠道模型对抗菌活性的评估
J Antimicrob Chemother. 2015 Jan;70(1):182-9. doi: 10.1093/jac/dku324. Epub 2014 Sep 3.
4
Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.医院病原体艰难梭菌中脯氨酸减少的分析
J Bacteriol. 2006 Dec;188(24):8487-95. doi: 10.1128/JB.01370-06. Epub 2006 Oct 13.
5
Clostridium difficile toxins: mechanism of action and role in disease.艰难梭菌毒素:作用机制及在疾病中的作用
Clin Microbiol Rev. 2005 Apr;18(2):247-63. doi: 10.1128/CMR.18.2.247-263.2005.
6
A clinical view of vancomycin in 1990.1990年对万古霉素的临床观察。
Tex Heart Inst J. 1990;17(1):5-9.
7
Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE.通过热休克改善艰难梭菌的分离及采用十二烷基硫酸钠聚丙烯酰胺凝胶电泳对分离菌株进行分型
Eur J Epidemiol. 1993 May;9(3):327-34. doi: 10.1007/BF00146272.
8
Clostridium difficile: clinical disease and diagnosis.艰难梭菌:临床疾病与诊断
Clin Microbiol Rev. 1993 Jul;6(3):251-65. doi: 10.1128/CMR.6.3.251.
9
Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.布拉氏酵母菌预防仓鼠克林霉素诱导的死亡
Antimicrob Agents Chemother. 1984 Oct;26(4):552-6. doi: 10.1128/AAC.26.4.552.
10
Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea.
Infection. 1985 May-Jun;13(3):97-101. doi: 10.1007/BF01642866.
Scand J Gastroenterol. 1981;16(4):465-8. doi: 10.3109/00365528109181999.
4
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.来自不同患者群体的艰难梭菌分离株的分离率和产毒潜力。
Gastroenterology. 1981 Jul;81(1):5-9.
5
Antimicrobial agent-associated colitis and diarrhea.抗菌药物相关性结肠炎和腹泻
West J Med. 1980 Aug;133(2):115-23.
6
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.口服万古霉素治疗抗生素相关性假膜性结肠炎后的症状性复发。
Gastroenterology. 1980 Mar;78(3):431-4.
7
Pseudomembranous colitis after treatment with metronidazole.甲硝唑治疗后发生的伪膜性结肠炎。
Br Med J (Clin Res Ed). 1981 Mar 14;282(6267):864-5. doi: 10.1136/bmj.282.6267.864-a.
8
Diagnostic features of clindamycin-associated pseudomembranous colitis.克林霉素相关性假膜性结肠炎的诊断特征。
N Engl J Med. 1974 Apr 11;290(15):841-3. doi: 10.1056/NEJM197404112901508.
9
Diagnosis of pseudomembranous colitis.伪膜性结肠炎的诊断
Br Med J. 1978 Mar 18;1(6114):675-8. doi: 10.1136/bmj.1.6114.675.
10
Relapse of pseudomembranous colitis after vancomycin therapy.
N Engl J Med. 1979 Aug 23;301(8):414-5. doi: 10.1056/NEJM197908233010806.